The previous parts of this series described historical patterns: methodological weaknesses, late discovery of contaminations, liability exemptions. Part 5 shows that these patterns with the mRNA vaccine are not the exception but the rule.
The Contaminated Control Group #
Pfizer vaccinated the placebo group of the BNT162b2 trial after 6 months. That was in March 2021 — shortly after the emergency authorization.
This means there is no more long-term control group. The question “what happens with unvaccinated people over 2, 3, 5 years?” can no longer be answered from the trial. This is documented, admitted, and was justified as an “ethical necessity.”
For safety assessment it means: all long-term data is structurally missing.
The Different Substance #
Dr. Helmut Sterz, former Chief Toxicologist at Pfizer Europe, stated in testimony before the Bundestag Enquete Commission:
“For the clinical trials before approval, a highly pure substance was used. It was too expensive for mass production. The population received a vaccine manufactured using the bacterium Escherichia coli.”
This means: what was approved and what was injected were not the same. The approval is based on a highly pure substance. The population received a cheaper manufacturing process with known contaminations.
This is not a whistleblower rumor. It is the statement of the man who at Pfizer was responsible for exactly these questions.
DNA Contaminations #
The different manufacturing process results in significant DNA contaminations with bacterial DNA — documented by independent researcher Kevin McKernan (McKernan et al., OSF Preprints) and confirmed by the Sterz testimony.
The consequence could be, according to Sterz, “a significantly elevated cancer risk.” Prof. Bhakdi reports a published individual case in which the incorporation of foreign DNA into the human genome was demonstrated — with turbo-cancer formation as the result.
The pattern from Part 3 (SV40) repeats: contamination in the manufacturing process → mass distribution → post-market discovery.
The BGH Ruling: The Turning Point #
On March 9, 2026, the Federal Court of Justice ruled: manufacturers must disclose information on request. The burden of proof shifts — it is not the injured parties who must prove that the contaminations cause harm. The manufacturers must prove that they do not.
And as Sterz explains: in cases of proven fraud, the EU liability exemption no longer applies. The question is no longer whether this evidence will be produced, but when.
The Bridge to Parts 1-4 #
- Part 1 (tetanus contradiction): With mRNA too, there are no uniform international recommendations on booster intervals
- Part 2 (placebo problem): Pfizer’s “placebo” contained the same lipid nanoparticle carrier as the active substance — just without mRNA
- Part 3 (historical patterns): DNA contamination like SV40, different production batch than the approved one like the Cutter Incident
- Part 4 (liability): EU assumed liability, Sterz: in cases of fraud this doesn’t apply
Sources:
- Vox (2021): Covid vaccine trial unblinding — vox.com
- Bhakdi/Sterz: The human was genetically altered — elizaonsteroids.org
- BGH ruling March 2026: Turning point in vaccine damage cases — elizaonsteroids.org
